Linde Forecast, price target & analysts
Linde Target price 2026 - Analyst rating & recommendation
Linde Classifications & Recommendation
Linde Price Target
| Target Price | $561.00 |
| Price | $493.22 |
| Potential | 13.74% |
| Number of Estimates | 28 |
| 28 Analysts have issued a price target Linde 2027 . The average Linde target price is $561.00. This is 13.74% higher than the current stock price. The highest price target is $642.60 30.29% , the lowest is $404.00 18.09% . | |
| A rating was issued by 31 analysts: 22 Analysts recommend Linde to buy, 7 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Linde stock has an average upside potential 2027 of 13.74% . Most analysts recommend the Linde stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
29 Analysts have issued a sales forecast Linde 2026 . The average Linde sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
27 Analysts have issued an Linde EBITDA forecast 2026. The average Linde EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
31 Linde Analysts have issued a net profit forecast 2026. The average Linde net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
Current Linde Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
➜
Overweight
|
Initiated | Oct 13 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Oct 07 2026 |
| UBS |
Buy
➜
Buy
|
Unchanged | Oct 05 2026 |
| Argus Research |
Buy
➜
Buy
|
Unchanged | Sep 28 2026 |
| Keybanc |
➜
Overweight
|
Initiated | Sep 11 2026 |
| BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Aug 10 2026 |
| Bernstein |
Outperform
➜
Outperform
|
Unchanged | Aug 03 2026 |
| Analyst Rating | Date |
|---|---|
|
Initiated
Barclays:
➜
Overweight
|
Oct 13 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Oct 07 2026 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Oct 05 2026 |
|
Unchanged
Argus Research:
Buy
➜
Buy
|
Sep 28 2026 |
|
Initiated
Keybanc:
➜
Overweight
|
Sep 11 2026 |
|
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Aug 10 2026 |
|
Unchanged
Bernstein:
Outperform
➜
Outperform
|
Aug 03 2026 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
